Ascentage Pharma’s olverembatinib approved in Macau for leukaemia
Ascentage Pharma has obtained approval for its new BCR-ABL1 [a gene sequence found in certain forms of leukaemia] tyrosine kinase…
Ascentage Pharma has obtained approval for its new BCR-ABL1 [a gene sequence found in certain forms of leukaemia] tyrosine kinase…
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting approval in…
GSK has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Omjjara (momelotinib) to treat patients with…
The European Commission has granted marketing authorisation to Sobi’s Altuvoct (efanesoctocog alfa) for the treatment and prevention of bleeds and…
The US Food and Drug Administration (FDA) has approved Amgen’s BLINCYTO (blinatumomab) for CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukaemia (B-ALL)…
The US Food and Drug Administration (FDA) has granted approval for Geron’s RYTELO (imetelstat) for adults with low to intermediate-1…
The US Food and Drug Administration (FDA) has granted orphan drug designation to Be Biopharma’s (Be Bio) BE-101 for the…
The UK's National Health Service (NHS) has announced plans to offer Pfizer's Voxelotor (Oxbryta), a new treatment option for sickle…
Sanofi’s rilzabrutinib has found success and met the primary endpoint in the Phase III LUNA trial in heavily pre-treated immune…
Syros Pharmaceuticals has received fast track designation from the US Food and Drug Administration (FDA) for tamibarotene to treat newly…